FDA Hatch/Waxman Fix Proposal Includes “Beefed-Up” Patent Declarations
This article was originally published in The Tan Sheet
Executive Summary
FDA is considering requiring innovator companies to provide more information about patents they file for listing in the Orange Book as one way of addressing Hatch/Waxman loopholes